Mohammed Anass Tanveer

Jun 27, 2024 | mdpi.com | Mohammed Hussain |Brent A. Stanfield |David Bernstein |Mohammed Anass Tanveer

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 1, 2023 | journals.lww.com | Mohammed Anass Tanveer

Introduction Rituximab (RTX) has been widely used in the treatment of autoimmune rheumatic diseases (AIRDs), owing to its pleiotropic effects on the immune system.